NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

No, he can’t say that, because publication route was decided before unblinding. Listen closely BSB, even Ex thinks they succeeded on four endpoints — including the primary endpoint.

There are six endpoints in all.

Most on this message board believe DCVax-l either met five of six, or six of six endpoints.

What he did tell femike, was that they are working toward possible approval, and that they can’t rush the Journal, but the lack of a current public TLD announcement wasn’t slowing any efforts to try and obtain approval.